6. Kershaw WE, Jamison DG, Nugent D, Duke BOL. Preliminary observalus. In: Clapp JP, ed. Species diagnostic protocols: PCR and other nucleic acid methods. Vol 50. Totowa, NJ: Humana Press, 1996:293 -tions on the depth distribution of the microfilariae of Onchocerca volvulus in the skin and its relation to the reservoir of infection to the fly. Despite extensive efforts, the development of a broadly efthat are being studied as potential vaccine components [1] . SERA appears to be located in the parasitophorous vacuole fective malaria vaccine remains an elusive goal. Contributing to difficulties in vaccine development, malarial proteins that are surrounding the intraerythrocytic schizont [3] and on the surexposed to the human immune response are often antigenically face of free merozoites [4], so it is likely accessible to circulatdiverse, and immunologic pressure appears to elicit antigenic ing antibodies and other mediators of the host immune revariation [1] . It seems appropriate, therefore, to consider as sponse. Supporting the consideration of SERA as a vaccine vaccine components malarial proteins that are targets of the component, immunization with intact SERA [5] and aminohost immune response but that are antigenically conserved.
terminal SERA fragments [6] induced protective immunity in Among such proteins should be essential enzymes that are monkeys. The role of the carboxy-terminal portion of SERA conserved because of the constraints imposed by their enzyin immune responses has been relatively little studied, although matic functions. a hybrid vaccine that included carboxy-terminal SERA fragThe Plasmodium falciparum serine repeat antigen (SERA) ments also induced protective immunity in monkeys [7] , and [2] is one of a number of erythrocytic-stage malarial proteins rat antisera produced against this portion of SERA inhibited the growth of malaria parasites in vitro [8] . In addition, in studies of carboxy-terminal fragments of SERA homologues from the murine parasite Plasmodium vinckei, mice immunized protease domains of SERA and SERPH are well-conserved;
States with either no history or only an uncertain, very distant their amino acid sequences are 56% identical, although in history of malaria.
SERA the predicted active site cysteine has been replaced by
Characterization of humoral responses. IgG responses directed against SERA and SERPH protease domains were assessed a serine [10] . The SERA protease domain is also highly conby ELISA. Purified SERA and SERPH protease domains (10 mg/ served among P. falciparum isolates; the amino acid sequences mL in 0.1 M sodium bicarbonate, pH 8.3; 50 mL/well), purified of 10 independent isolates were identical, except for a single control thioredoxin (10 mg/mL), and a soluble extract of P. falcipaconservative substitution in some field isolates [11] . As the rum trophozoites (20 mg/mL) were fixed to microtiter plates (Imconserved protease domains appear to be exposed to circulating 
Materials and Methods

sera.
To study the subclass specificity of humoral responses to P. Parasite culture. It-strain P. falciparum parasites were culfalciparum protease domains, the presence of antibodies against tured, and extracts of P. falciparum soluble proteins were prepared the protease domains was evaluated in pooled sera, diluted at 1:100 by saponin lysis of erythrocytes as previously described [12] . and 1:800, by ELISA, as discussed above, with second antibodies Amplification of SERA and SERPH protease domains. P. fal-(Sigma, St. Louis) directed against each of the four human IgG ciparum genomic DNA was purified by standard methods, and subclasses. DNA encoding the protease domains of SERA and SERPH was amplified by polymerase chain reaction. The primers used were 5-TGTAATAAAGAATATTGTAA-3 and 5-GTGAATAAA- against a soluble extract of P. falciparum trophozoites (figure before harvesting the bacteria. Expressed polypeptides were affin-1), indicating that the sera were appropriate to evaluate reity-purified on a nickel nitrilo-triacetic acid resin column (Qiagen, Chatsworth, CA), as previously described [9] . sponses of malaria-immune persons. Most of the African sera / 9d4a$$jy27 05-28-98 08:11:50 jinfas UC: J Infect soluble trophozoite extract (E) were determined for pools of sera from nm (OD 405 ), were compared against thioredoxin (T; 10 mg/mL), SERA nonimmune controls and malaria-immune persons from The Gambia (S; 10 mg/mL), SERPH (H; 10 mg/mL), and a soluble extract of P.
Results
GTTAAAATGACA
and Uganda. Subclass levels were determined by ELISA with second falciparum trophozoites (E; 20 mg/mL) for nonimmune controls (n antibodies directed against each of 4 human IgG subclasses. Å 7) and malaria-immune persons from The Gambia (n Å 20) and Uganda (n Å 15). Each data point is mean of duplicate readings. Means for each group are represented by horizontal bars.
Discussion
The P. falciparum proteins SERA and SERPH contain conalso demonstrated antibody responses directed against the SERA and SERPH protease domains (figure 1). In general, the served protease domains that are likely accessible to circulating antibodies and that may mediate critical functions in mature magnitude of responses to the two antigens was similar for a given individual. Responses of nonimmune controls to both erythrocytic parasites. We hypothesize that antibodies directed against these domains inhibit key functions and thus contribute plasmodial extract and the protease domains were much lower than those of Africans. To control for nonspecific hyperreactivto antimalarial immunity. To begin to test this hypothesis, we evaluated humoral responses against the protease domains of ity of the immune sera, responses were also tested against bovine serum albumin (BSA; not shown) and the E. coli protein SERA and SERPH. Persons from two regions of Africa in which falciparum malaria is highly endemic, but not nonimthioredoxin, which was expressed in E. coli and purified exactly as were the SERA and SERPH protease domains. Responses mune controls, demonstrated potent humoral responses against the protease domains. of the immune sera to thioredoxin were higher in Africans than in controls and somewhat higher than those to BSA, suggesting
Responses were quantitatively greater to SERPH than SERA. It is not clear whether this difference relates to a difference in that some of the reactivity of African sera against E. coliexpressed antigens was due to nonspecific hyperreactivity the antigenicity of the two protease domains or to the fact that the SERPH construct included an additional 85 amino acids against E. coli proteins. However, reactivity to SERA and SERPH was consistently higher than that against the controls, carboxy-terminal to the protease domain. Reactivity with the E. coli -expressed thioredoxin control was greater in the Uganparticularly with the Gambian sera, in which reactivity with thioredoxin was low.
dan than the Gambian sera, perhaps because of differences in infection rates with human immunodeficiency virus or other Subclass specificity of humoral responses to SERA and SERPH protease domains. Samples from nonimmune conpathogens between the groups. The increased nonspecific reactivity of the Ugandan sera served to diminish the difference trols and immune populations were pooled, and the presence of antibodies against the protease domains was evaluated by between responses to the control antigen and the SERA and SERPH protease domains, but quantitative responses to the ELISA with second antibodies directed against each of the four human IgG subclasses (figure 2). In analyses using 1:100 and protease domains in sera from the two regions were similar. Overall, the results clearly indicated that specific antibody re-1:800 (not shown) dilutions of antisera, antibodies directed against P. falciparum extracts and the SERA and SERPH protesponses were directed by malaria-immune Africans against the protease domains of SERA and SERPH. ase domains were primarily of the IgG1 subclass.
